terazosin

Generic: terazosin

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler preferred pharmaceuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8171
Product ID 68788-8171_933b040f-e49e-4ff9-a6f2-1124b97bbe57
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075614
Listing Expiration 2026-12-31
Marketing Start 2022-04-25

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888171
Hyphenated Format 68788-8171

Supplemental Identifiers

RxCUI
313217
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA075614 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (68788-8171-3)
source: ndc

Packages (1)

68788-8171-3 30 CAPSULE in 1 BOTTLE (68788-8171-3)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "933b040f-e49e-4ff9-a6f2-1124b97bbe57", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["a78f74ce-1c53-41ea-878e-13674db10a67"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-8171-3)", "package_ndc": "68788-8171-3", "marketing_start_date": "20220425"}], "brand_name": "terazosin", "product_id": "68788-8171_933b040f-e49e-4ff9-a6f2-1124b97bbe57", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "68788-8171", "generic_name": "terazosin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075614", "marketing_category": "ANDA", "marketing_start_date": "20220425", "listing_expiration_date": "20261231"}